LifeMD Plans to Share Financial Results on Upcoming Call

Author: Dylan Bailey Updated: 02-25-2025 08:34 AM

Upcoming Financial Results Conference Call

LifeMD, Inc. (NASDAQ: LFMD), a frontrunner in providing virtual primary care services, has announced its schedule to report financial results for the three and twelve months ending December 31, 2024. This update is set to be released following the closure of the U.S. financial markets on March 10, 2025. Investors and interested parties are encouraged to participate in the conference call commencing at 4:30 p.m. Eastern time on the same day.

Conference Call Participation

Participants can join the call using the following dial-in numbers: for toll-free access, dial 800-225-9448, and for international access, dial 203-518-9708. Ensure to mention the Conference ID, which is LIFEMD, to join the viewer line smoothly. Live and archived audio webcasts will be available, providing a comprehensive overview of the company's performance and strategic outlook.

Overview of LifeMD, Inc.

LifeMD offers a remarkable suite of virtual healthcare services designed to enhance patient accessibility and engagement. The company employs cutting-edge telemedicine solutions, extensive laboratory and pharmacy capabilities, and specialized treatments covering over 200 health conditions. This includes areas such as primary care, men's and women's health, weight management, and hormone therapy.

Innovative Healthcare Solutions

The company leverages a proprietary digital care platform, a robust network of a 50-state affiliated medical group, and a large-scale engaged pharmacy service. With a dedicated care center located in the United States, LifeMD positions itself as a leader in affordable healthcare access. Their approach is centered around ensuring that quality health solutions are reachable for all individuals, showcasing a commitment to meeting diverse patient needs.

Company's Future Outlook

LifeMD's growth trajectory continues to expand as they consistently innovate their service offerings. By focusing on technologies that promote virtual patient interactions, the company aims to reshape how healthcare is delivered. Their commitment to enhancing patient care through digital platforms provides them with a competitive advantage in the ever-evolving health industry landscape.

Contact Information for Inquiries

For investor-related concerns, reach out to Marc Benathen, Chief Financial Officer of LifeMD, via email at marc@lifemd.com. Media inquiries can be directed to Jessica Friedeman, Chief Marketing Officer, at press@lifemd.com. Communication channels are open for stakeholders to engage directly with the leadership team for insights and updates regarding the company.

Frequently Asked Questions

What financial results will LifeMD report?

LifeMD will disclose its financial results for the three and twelve months ending December 31, 2024.

When will the conference call take place?

The conference call is scheduled for March 10, 2025, at 4:30 p.m. Eastern time.

How can I participate in the conference call?

Join the conference call by dialing 800-225-9448 (toll-free) or 203-518-9708 (international), and use the Conference ID LIFEMD.

What services does LifeMD provide?

LifeMD offers virtual primary care, telemedicine services, and specialized treatments for over 200 health conditions.

Who can I contact for more information?

Contact Marc Benathen, CFO for investor inquiries at marc@lifemd.com, or Jessica Friedeman, CMO for media inquiries at press@lifemd.com.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.